Embryonic stem cells are pluripotent cells derived from the inner cell mass of the early blastocyst, capable of indefinite self-renewal in culture and of differentiating into derivatives of all three germ layers. Their pluripotency is sustained by a core regulatory network of transcription factors, including OCT4, S…
Embryonic stem cells are pluripotent cells derived from the inner cell mass of the early blastocyst, capable of indefinite self-renewal in culture and of differentiating into derivatives of all three germ layers. Their pluripotency is sustained by a core regulatory network of transcription factors, including OCT4, SOX2, and NANOG, whose expression can be modulated by microRNAs and other regulators; loss of this network triggers lineage commitment. Because they can in principle generate any cell type of the body, embryonic stem cells are a foundational model for studying early development, lineage specification, and the molecular control of differentiation, and they serve as a benchmark for engineered pluripotent cells. Their potential applications in regenerative medicine, disease modeling, and drug testing are accompanied by ethical considerations arising from their derivation from embryos. Research relevant to this topic includes microRNA regulation of OCT4 promoter activity, biocompatible scaffolds for transplanting pluripotent-cell derivatives and modeling neural recovery, estrogen-receptor expression in hypothalamic stem cells, the molecular control of human embryonic development, the differentiation potential and therapeutic use of stem cells in regenerative medicine, and the ethical and interdisciplinary debates surrounding modern stem-cell research and therapy.
11 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The 11 articles above have been cited 39 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
A sample of recent works citing this journal's research on Embryonic Stem Cells, linking to each citing work.